A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice

Genes, Brain and Behavior

Volumn 8, Issue 8, 2009, Pages 795-805

  Bryant, C D ^a   Chang, H P ^a   Zhang, J ^a   Wiltshire, T ^b   Tarantino, L M ^c   Palmer, A A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

A J; C57BL 6J; Chromosome 11; Chromosome substitution stains; CSS; F 2; Fentanyl; Locomotor activity; Methamphetamine; Opioid; Psychostimulant; QTL; Stimulants

Indexed keywords

FENTANYL; METHAMPHETAMINE; OPIATE; SODIUM CHLORIDE;

A J MOUSE; ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CHROMOSOME 11; CHROMOSOME SUBSTITUTION STRAIN; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HAPLOTYPE MAP; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; STIMULUS RESPONSE; STRAIN DIFFERENCE;

ANALGESICS, OPIOID; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG RESISTANCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY; QUANTITATIVE TRAIT LOCI; RECEPTORS, OPIOID, MU; SUBSTANCE-RELATED DISORDERS;

MUS;

EID: 70449382310     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2009.00525.x     Document Type: Article

References (41)

1. Belknap, J.K. (2003) Chromosome substitution strains: some quantitative considerations for genome scans and fine mapping. Mamm Genome 14, 723 732.
2. Binda, F., Dipace, C., Bowton, E., Robertson, S.D., Lute, B.J., Fog, J.U., Zhang, M., Sen, N., Colbran, R.J., Gnegy, M.E., Gether, U., Javitch, J.A., Erreger, K. & Galli, A. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Molecular Pharmacol 74, 1101 1108.
3. Bogue, M. (2003) Mouse Phenome Project: understanding human biology through mouse genetics and genomics. J Appl Physiol 95, 1335 1337.
4. Borgkvist, A., Usiello, A., Greengard, P. & Fisone, G. (2007) Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology 32, 1995 2003.
5. Brodkin, E.S., Carlezon, W.A. Jr., Haile, C.N., Kosten, T.A., Heninger, G.R. & Nestler, E.J. (1998) Genetic analysis of behavioral, neuroendocrine, and biochemical parameters in inbred rodents: initial studies in Lewis and Fischer 344 rats and in A/J and C57BL/6J mice. Brain Res 805, 55 68.
6. Broman, K.W., Wu, H., Sen, S. & Churchill, G.A. (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19, 889 890.
7. Bryant, C.D., Graham, M.E., Distler, M.G., Munoz, M.B., Li, D., Vezina, P., Sokoloff, G. & Palmer, A.A. (2009a) A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology 203, 703 711.
8. Bryant, C.D., Roberts, K.W., Culbertson, C.S., Le, A., Evans, C.J. & Fanselow, M.S. (2009b) Pavlovian conditioning of multiple opioid-like responses in mice. Drug Alcohol Depend 103, 74 83.
9. Chesler, E.J., Lu, L., Wang, J., Williams, R.W. & Manly, K.F. (2004) WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nat Neurosci 7, 485 486.
10. Di Chiara, G. & Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85, 5274 5278.
11. Fienberg, A.A., Hiroi, N., Mermelstein, P.G. et al. (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838 842.
12. Gill, K.J. & Boyle, A.E. (2005) Genetic basis for the psychostimulant effects of nicotine: a quantitative trait locus analysis in AcB/BcA recombinant congenic mice. Genes Brain Behav 4, 401 411.
13. Greengard, P. (2001) The neurobiology of slow synaptic transmission. Science 294, 1024 1030.
14. Han, W., Saegusa, H., Zong, S. & Tanabe, T. (2002) Altered cocaine effects in mice lacking Ca(v)2.3 (alpha(1E)) calcium channel. Biochem Biophys Res Commun 299, 299 304.
15. Hori, Y., Takeda, H., Tsuji, M. & Matsumiya, T. (1998) Differentiation of the inhibitory effects of calcium antagonists on abnormal behaviors induced by methamphetamine or phencyclidine. Pharmacology 56, 165 174.
16. Johnson, B.A., Roache, J.D., Bordnick, P.S. & Ait-Daoud, N. (1999) Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Psychopharmacology 144, 295 300.
17. Koshikawa, N., Mori, E., Oka, K., Nomura, H., Yatsushige, N. & Maruyama, Y. (1989) Effects of SCH23390 injection into the dorsal striatum and nucleus accumbens on methamphetamine-induced gnawing and hyperlocomotion in rats. J Nihon Univ Sch Dent 31, 451 457.
18. Levran, O., Londono, D., O'Hara, K., Nielsen, D.A., Peles, E., Rotrosen, J., Casadonte, P., Linzy, S., Randesi, M., Ott, J., Adelson, M. & Kreek, M.J. (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7, 720 729.
19. Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y., Fienberg, A.A., Bibb, J.A., Fredholm, B.B., Nairn, A.C., Greengard, P. & Fisone, G. (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418, 774 778.
20. McClurg, P., Pletcher, M.T., Wiltshire, T. & Su, A.I. (2006) Comparative analysis of haplotype association mapping algorithms. BMC Bioinformatics 7, 61.
21. Mills, K., Arsah, T.A., Ali, S.F. & Shockley, D.C. (1998) Calcium channel antagonist isradipine attenuates cocaine-induced motor activity in rats: correlation with brain monoamine levels. Ann N Y Acad Sci 844, 201 207.
22. Nadeau, J.H., Singer, J.B., Matin, A. & Lander, E.S. (2000) Analysing complex genetic traits with chromosome substitution strains. Nat Genet 24, 221 225.
23. Ouimet, C.C., Miller, P.E., Hemmings, H.C. Jr., Walaas, S.I. & Greengard, P. (1984) DARPP-32, a dopamine- and adenosine 3′:5′- monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4, 111 124.
24. Palmer, A.A., Verbitsky, M., Suresh, R., Kamens, H.M., Reed, C.L., Li, N., Burkhart-Kasch, S., McKinnon, C.S., Belknap, J.K., Gilliam, T.C. & Phillips, T.J. (2005) Gene expression differences in mice divergently selected for methamphetamine sensitivity. Mamm Genome 16, 291 305.
25. Pani, L., Kuzmin, A., Diana, M., De Montis, G., Gessa, G.L. & Rossetti, Z.L. (1990) Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol 190, 217 221.
26. Pani, L., Kuzmin, A., Martellotta, M.C., Gessa, G.L. & Fratta, W. (1991) The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res Bull 26, 445 447.
27. Phillips, T.J., Kamens, H.M. & Wheeler, J.M. (2008) Behavioral genetic contributions to the study of addiction-related amphetamine effects. Neurosci Biobehav Rev 32, 707 759.
28. Pierce, R.C., Quick, E.A., Reeder, D.C., Morgan, Z.R. & Kalivas, P.W. (1998) Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 286, 1171 1176.
29. Pletcher, M.T., McClurg, P., Batalov, S., Su, A.I., Barnes, S.W., Lagler, E., Korstanje, R., Wang, X., Nusskern, D., Bogue, M.A., Mural, R.J., Paigen, B. & Wiltshire, T. (2004) Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol 2, e393.
30. Shifman, S., Bell, J.T., Copley, R.R., Taylor, M.S., Williams, R.W., Mott, R. & Flint, J. (2006) A high-resolution single nucleotide polymorphism genetic map of the mouse genome. PLoS Biol 4, e395.
31. Singer, J.B., Hill, A.E., Burrage, L.C., Olszens, K.R., Song, J., Justice, M., O'Brien, W.E., Conti, D.V., Witte, J.S., Lander, E.S. & Nadeau, J.H. (2004) Genetic dissection of complex traits with chromosome substitution strains of mice. Science 304, 445 448.
32. Snyder, G.L., Allen, P.B., Fienberg, A.A., Valle, C.G., Huganir, R.L., Nairn, A.C. & Greengard, P. (2000) Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 20, 4480 4488.
33. Torres, G.E. (2006) The dopamine transporter proteome. J Neurochem 97 (Suppl 1 3 10.
34. Veenstra-VanderWeele, J., Qaadir, A., Palmer, A.A., Cook, E.H. Jr. & de Wit, H. (2006) Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology 31, 1056 1063.
35. Walaas, S.I., Aswad, D.W. & Greengard, P. (1983) A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69 71.
36. Williams, R., Lim J.E., Harr B., Wing C., Walters R., Distler M.G., Meike T., Wu C., Wiltshire T., Su A.I., Sokoloff G., Tarantino L.M., Borevitz J.O. & Palmer A.A. (2009) A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior. PLoS One 4, e4649.
37. Wiltshire, T., Pletcher, M.T., Batalov, S., Barnes, S.W., Tarantino, L.M., Cooke, M.P., Wu, H., Smylie, K., Santrosyan, A., Copeland, N.G., Jenkins, N.A., Kalush, F., Mural, R.J., Glynne, R.J., Kay, S.A., Adams, M.D. & Fletcher, C.F. (2003) Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci U S A 100, 3380 3385.
38. Wise, R.A. & Bozarth, M.A. (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94, 469 492.
39. Zachariou, V., Benoit-Marand, M., Allen, P.B., Ingrassia, P., Fienberg, A.A., Gonon, F., Greengard, P. & Picciotto, M.R. (2002) Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or inhibitor 1. Biol Psychiatry 51, 612 620.
40. Zachariou, V., Sgambato-Faure, V., Sasaki, T., Svenningsson, P., Berton, O., Fienberg, A.A., Nairn, A.C., Greengard, P. & Nestler, E.J. (2006) Phosphorylation of DARPP-32 at threonine-34 is required for cocaine action. Neuropsychopharmacology 31, 555 562.
41. Zhang, W., Efanov, A., Yang, S.N., Fried, G., Kolare, S., Brown, H., Zaitsev, S., Berggren, P.O. & Meister, B. (2000) Munc-18 associates with syntaxin and serves as a negative regulator of exocytosis in the pancreatic beta -cell. J Biol Chem 275, 41521 41527.